Description
The combined detection of four “phospholipid antibodies” lends this test particularly high clinical sensitivity. ORGENTEC’s test systems for the isolated detection of the individual phospholipid autoantibodies, the Anti-beta-2-glyoprotein-I test, or the ThromboCombo ELISA can subsequently be used for the differentiated quantitative determination of the autoantibodies.
Anti-Phospholipid Screen IgG is an ELISA-based screening test for the quantitative determination of IgG antibodies against cardiolipin, phosphatidyl serine, phosphatidyl inositol, phosphatidic acid, and cofactor beta-2-glycoprotein I in human serum or plasma. This test is an outstanding tool for the serological detection of primary and secondary antiphospholipid syndrome.
